INTRODUCTION
============

Colorectal cancer is the third most common cancer in Korea following thyroid cancer and stomach cancer. Although it occurs mainly in patients older than 50 years, the number of patients with colon cancer in their 40s or younger is increasing \[[@B1]\]. Colon cancer is caused by environmental factors such as dietary habits, smoking, and frequent alcohol consumption as well as genetic factors. Therefore, smoking cessation, alcohol abstinence, restriction of red meat intake, and adequate vegetable intake are recommended to reduce the risk of colorectal cancer \[[@B2][@B3][@B4]\]. Many studies have shown that food is an important carcinogen, and the risk of colon cancer is known to be closely related to dietary factors. Consumption of antioxidant vitamins, green vegetables, and animal fat are associated with the development of colorectal polyps \[[@B5][@B6][@B7]\]. Although there are many studies of dietary factors such as excessive animal fat, sugar, alcohol consumption, and fiber intake, the results are not consistent due to the variability of study subjects and methods among studies \[[@B8][@B9]\].

Colonoscopically observed adenoma is a pathologic precursor lesion of colon cancer. Alcohol consumption, smoking, and obesity increase the risk of colon polyps. Hyperglycemia and hypertriglyceridemia are closely related to the presence of colon polyps \[[@B10][@B11]\]. Obesity, high blood sugar, and elevated blood pressure are major diagnostic factors for metabolic syndrome. According to Wang et al. \[[@B12]\], metabolic syndrome is also associated with the development of colonic polyps, and the greater the number of metabolic syndrome diagnostic criteria, the greater the incidence of colonic polyps. Insulin resistance is also known to play an important role in the development of metabolic syndrome directly or indirectly. Metabolic syndrome factors include insulin, estrogen, cytokines, and growth factors \[[@B13][@B14][@B15]\]. One study indicates that these factors affect the association between the metabolic syndrome and colorectal cancer and engage in the component of colorectal cancer screening system used in other countries \[[@B16][@B17]\].

The risk of metabolic syndrome is higher in cancer patients than in healthy people even after surgery, radiotherapy, hormone therapy, the recovery period, and the management period after a cancer diagnosis. In addition, in the case of colorectal cancer, it is very important to maintain a healthy lifestyle through weight management and balanced diet during treatment.

There have been many studies which investigated the aspect of metabolic syndrome in the development of various chronic diseases. However, there are very few studies on metabolic syndrome and dietary factors in colorectal cancer patients. The aim of this study was to investigate the incidence of metabolic syndrome in patients with colorectal cancer and to compare whether nutrient intake differed according to the presence or absence of metabolic syndrome.

MATERIALS AND METHODS
=====================

Patients
--------

The subjects of the study were the patients who were diagnosed colorectal cancer at general hospitals and were preparing for surgery. The purpose of this study and the contents of the study were explained and the research consent was obtained. Patients were asked to agree on their participation in the study and direct interviews were conducted to ensure the validity of all data. The total number of patients under investigation was 168, but the number of final research subjects was 143, except for patients who withdrew and information was omitted. And chronic diseases such as diabetes, hyperlipidemia and hypertension were excluded.

Definition of metabolic syndrome
--------------------------------

In addition, to define the metabolic syndrome, subjects with 3 or more risk factors for metabolic syndrome were diagnosed as the metabolic syndrome group based on National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) and Asia-Pacific criteria. Among the 5 factors of metabolic syndrome, waist circumference, and blood pressure were directly measured. Blood was collected from the upper arm vein after 12 hours of fasting for blood tests. Serum centrifuged at 2,000--4,000 rpm for 10 minutes was analyzed using a biochemical automatic analyzer (Hitachi 7170; Hitachi Ltd., Tokyo, Japan). Blood pressure were measured using an automatic sphygmomanometer (HEM-770A; OMRON, Kyoto, Japan) after the blood pressure was stabilized, and the mean blood pressure of the right upper arm was measured twice. The waist circumference was measured at the umbilicus in a comfortable posture using a tape measure, and the widest part between the upper and lower ends of the iliac bone was measured around the hip. A blood glucose, triglycerides, and high-density lipoprotein (HDL)-cholesterol were recorded as a result of blood tests. The subjects were divided into the metabolic syndrome group (n = 49) and the normal group (n = 94) according to the risk factors of metabolic syndrome.

Anthropometric and lifestyle survey
-----------------------------------

Age, sex, height, and body weight were examined retrospectively. Body mass index (BMI) was calculated from obtained height and weight. The waist circumference was measured by spreading the legs 25 to 30 cm, spreading the weight evenly, measuring tape measure to 0.1 cm so that the skin was not pressed by the tape measure at the lowest position of the ribs and the highest position of the pelvis. Drinking and smoking are categorized as drinking or smokers if they are present or have been performed within the last 1 month. Regular exercise was divided into subjects who exercised 3 or more times a week for at least 40 minutes.

Nutrient intake survey
----------------------

In order to evaluate nutrient intake, 3-day food record method were conducted and analyzed using the computer-aided nutritional analysis program (CAN-Pro 4.0; Korean Nutrition Society, Seoul, Korea). Energy 3 types of nutrients, fiber, vitamins and minerals, cholesterol and fatty acids were analyzed. The ratio of Polyunsaturated fatty acid:Monounsaturated fatty acid:Saturated fatty acid (P:M:S) by the way that the sum of total fatty acids was divided by the amount of polyunsaturated, monounsaturated or saturated fatty acids.

Statistical analysis
--------------------

To identify the difference in numeric values of factors between the groups, lifestyle, and nutrient factors were compared using independent t-tests and the equal-variance, χ^2^, or Fisher\'s exact test for categorical variables. Then, factors differing significantly between the 2 groups were subjected to univariate logistic regression analysis. These factors were included in initial multiple logistic regression and were eliminated in a step-by-step manner using backward selection. The Akaike information criterion (AIC) and Nagelkerke\'s R2 statistic were used to assess the fit of the multiple logistic regression model. All statistical analyses were conducted using SPSS software (version 14.0; SPSS Inc., Chicago, IL, USA) and R (version 3.1.3; The R Foundation for Statistical Computing, Vienna, Austria). The level of statistical significance was set at 5%.

RESULTS
=======

Comparison of anthropometric and lifestyle data
-----------------------------------------------

The proportion of patients accompanied with metabolic syndrome was 34.3% (n=49) among 143 subjects. The mean age was 52.5 years in the metabolic syndrome group and 58.0 in the normal group. In the metabolic syndrome group, 57.1% were men versus 62.8% in the normal group. The mean BMI was 27.7 kg/m^2^ in the metabolic syndrome group. Smoking rates were 42.9% in the metabolic syndrome group and 36.2% in the normal group, and the alcohol consumption rate was significantly higher in the metabolic syndrome group (61.2%) than in the normal group (42.6%). There was no significant difference in lower exercise rates between the groups, 26.5% and 26.6% for the metabolic and normal group, respectively. ([Table 1](#T1){ref-type="table"})

###### Anthropometric and life habit status

![](cnr-6-38-i001)

  Variables              Colorectal cancer (n = 143)                 
  ---------------------- ----------------------------- ------------- -----------
  Age, yr                52.5 ± 13.0                   58.0 ± 9.3    0.041
  Gender (male/female)   28/21                         59/35         0.056
  Height, cm             166.8 ± 15.3                  163.2 ± 8.4   0.362
  Weight, kg             62.6 ± 14.2                   54.0 ± 11.1   0.006
  BMI, kg/m^2^           27.7 ± 3.0                    23.4 ± 4.6    0.002
  Smoking                                                            0.048
                         Smoker                        21 (42.9)     34 (36.2)
                         Nonsmoker                     28 (57.1)     60 (63.8)
  Alcohol consumption                                                \< 0.001
                         Drinker                       30 (61.2)     40 (42.6)
                         Nondrinker                    19 (38.8)     54 (57.4)
  Regular exercise                                                   0.714
                         Yes                           13 (26.5)     25 (26.6)
                         No                            36 (81.2)     69 (78.1)

The data is presented as mean ± standard deviation for continuous variables by the independent t-test and frequency (%) for categorical variables by the χ^2^ test.

MS, metabolic syndrome group; BMI, body mass index.

Comparison of metabolic syndrome profile
----------------------------------------

There were significant differences between the 2 groups in terms of the metabolic syndrome diagnoses. Waist circumference, triglycerides, HDL-cholesterol, and systolic blood pressure were significantly different between the 2 groups. The average waist circumference was significantly higher in the metabolic syndrome group (93.3 cm) than in the normal group (76.3 cm), and the mean triglycerides were 189.1 mg/dL and 130.5 mg/dL, respectively. The metabolic syndrome group had higher HDL-cholesterol, 50.2 mg/dL vs. 38.5 mg/dL in the normal group. For systolic blood pressure, the metabolic syndrome group was 133.3 mmHg and the normal group was 116.4 mmHg. There was a difference in the level of triglycerides and HDL-cholesterol between groups, but the level of triglycerides were in normal range in both groups and HDL-cholesterol was in the normal range in the metabolic syndrome group ([Table 2](#T2){ref-type="table"}).

###### Metabolic syndrome profile

![](cnr-6-38-i002)

  Variables                                Colorectal cancer (n = 143)                                 
  ---------------------------------------- ----------------------------- -------------- -------------- ----------
  Waist circumference, cm (n = 82)^\*^     93.3 ± 3.8                    76.3 ± 6.2     0.001          
  Fasting plasma glucose, mg/dL (n = 51)   108.4 ± 10.7                  96.8 ± 8.4     0.125          
  Triglyceride, mg/dL (n = 63)             189.1 ± 55.3                  130.5 ± 38.6   0.003          
  HDL-cholesterol, mg/dL (n = 70)          38.5 ± 4.5                    50.2 ± 3.5     \< 0.001       
  Blood pressure, mmHg (n = 55)                                                                        
                                           Systolic                      133.3 ± 10.5   116.4 ± 13.4   \< 0.001
                                           Diastolic                     78.7 ± 5.6     71.2 ± 8.3     0.339

The data is presented as mean ± standard deviation for continuous variables by the independent t-test and frequency (%) for categorical variables by the χ^2^ test.

MS, metabolic syndrome group; HDL, high-density lipoprotein.

^\*^The number in parentheses means the number of subjects corresponding to each definition element of metabolic syndrome.

Comparison of nutrient intake status
------------------------------------

[Table 3](#T3){ref-type="table"} showing differences in nutrient intake between the 2 groups. The intake of energy, total fat, animal fat, total calcium, animal calcium, and phosphorus was significantly higher in the metabolic syndrome group, and the consumption of fiber, β-carotene, vitamin C, and folic acid was significantly higher in the normal group. There was no significant difference in other nutrients ([Table 3](#T3){ref-type="table"}).

###### Nutrient intake status

![](cnr-6-38-i003)

  Variables          Colorectal cancer (n = 143)                                       
  ------------------ ----------------------------- ------------------- --------------- -------
  Energy, kcal       2,048.1 ± 505.0               1,699.5 ± 492.2     0.005           
  Protein, g         88.9 ± 12.9                   67.2 ± 14.4         0.014           
                     Animal                        56.6 ± 28.0         43.9 ± 10.5     0.022
                     Plant                         36.3 ± 12.0         34.3 ± 13.7     0.358
  Fat, g             71.2 ± 14.1                   58.5 ± 13.5         0.001           
                     Animal                        42.0 ± 12.6         34.0 ± 10.2     0.031
                     Plant                         29.9 ± 10.3         23.6 ± 9.0      0.341
  Carbohydrate, g    257.6 ± 75.7                  229.4 ± 80.8        0.228           
  Fiber, g           124.8 ± 3.4                   193.8 ± 5.7         0.007           
  Calcium, mg        536.5 ± 190.5                 416.5 ± 204.6       0.004           
                     Animal                        337.8 ± 142.2       255.9 ± 181.9   0.010
                     Plant                         258.6 ± 123.4       230.6 ± 117.6   0.310
  Phosphorous, mg    1,281.2 ± 200.2               946.3 ± 326.1       0.006           
  Iron, mg           14.1 ± 4.8                    13.8 ± 3.0          0.459           
                     Animal                        4.6 ± 1.1           4.7 ± 1.3       0.701
                     Plant                         10.7 ± 2.7          10.9 ± 3.2      0.848
  Sodium, mg         4,343.8 ± 1,679.6             3,994.48± 1,152.7   0.206           
  Potassium, mg      2,071.0 ± 451.5               2,251.6 ± 336.2     0.152           
  Zinc, mg           8.1 ± 2.4                     8.5 ± 3.0           0.623           
  Vitamin A, μgRE    653.8 ± 227.6                 709.6 ± 334.1       0.570           
  Retinol, μg        140.4 ± 79.2                  151.8 ± 61.3        0.236           
  β-carotene, μg     2,966.9 ± 1,953.4             3,832.3 ± 1,730.7   0.026           
  Vitamin B~1~, mg   1.5 ± 0.3                     1.6 ± 0.3           0.497           
  Vitamin B~2~, mg   1.0 ± 0.3                     1.2 ± 0.3           0.123           
  Vitamin B~6~, mg   2.0 ± 0.7                     2.4 ± 0.6           0.086           
  Niacin, mgNE       17.0 ± 4.0                    18.8 ± 3.9          0.110           
  Vitamin C, mg      63.1 ± 34.0                   92.7 ± 21.3         \< 0.001        
  Folic acid, mg     206.6 ± 94.4                  262.2 ± 87.6        \< 0.042        
  Vitamin E, mg      12.7 ± 4.8                    12.6 ± 5.4          0.287           

The data is presented as mean ± standard deviation for continuous variables by the independent t-test.

MS, metabolic syndrome group.

Comparison of fat intake status
-------------------------------

We analyzed whether there was any difference in fat intake between the 2 groups. The intake of cholesterol, total fatty acid, saturated fatty acid, and monounsaturated fatty acid was significantly higher in the metabolic syndrome group than in the normal group. However, the ratio of polyunsaturated fatty acid to total fatty acid was not significantly different between the 2 groups ([Table 4](#T4){ref-type="table"}).

###### Fat intake status
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  Variables         Colorectal cancer (n = 143)                    
  ----------------- ----------------------------- ---------------- -------
  Cholesterol, mg   391.7 ± 143.8                 289.9 ± 159.5    0.002
  TFA, mg           38.6 ± 7.5                    29.4 ± 6.0       0.023
  SFA, mg           15.5 ± 5.5                    11.2 ± 3.6       0.001
  MUFA, mg          16.2 ± 6.4                    13.7 ± 5.2       0.044
  PUFA, mg          7.4 ± 2.6                     8.3 ± 3.0        0.095
  P:M:S ratio       0.54:1.05:1.00                0.67:1.13:1.00   0.231

The data is presented as mean ± standard deviation for continuous variables by the independent t-test.

MS, metabolic syndrome group; TFA, total fatty acid; SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid; P:M:S ratio, Polyunsaturated:Monounsaturated:Saturated fatty acids ratio.

Risk factors of metabolic syndrome in patients with colorectal cancer
---------------------------------------------------------------------

Factors which have shown significantly different values between groups in above results were further analysed for assessing the degree of relationship with metabolic syndrome. Significant results in single regression analysis were found for alcohol consumption, energy, vitamin C, folic acid, and total fatty acids intake. However, multiple regression analysis showed that BMI, alcohol consumption, intake of fat, fiber, vitamin C, folic acid, and total fatty acids had a significant effect on the incidence of metabolic syndrome in patients with colorectal cancer ([Table 5](#T5){ref-type="table"}).

###### Risk of the individual components of metabolic syndrome in patients with colorectal cancer (n = 143)

![](cnr-6-38-i005)

  Variables            Metabolic syndrome      
  -------------------- ----------------------- -----------------------
  BMI                  1.15 (0.90--1.48)       1.50 (1.15--1.96)^\*^
  Smoker               0.99 (0.95--1.03)       1.04 (0.97--1.11)
  Alchol consumption   1.19 (1.11--1.27)^†^    1.73 (1.64--1.83)^†^
  Energy               1.16 (0.94--1.28)^‡^    1.04 (0.84--1.22)
  Protein              1.01 (1.00--1.14)       1.11 (1.00--1.12)
  Fat                  1.01 (0.79--1.29)       1.51 (1.39--2.06)^\*^
  Fiber                0.96 (0.92--1.01)       0.93 (0.89--0.98)^\*^
  Calcium              0.95 (0.90--1.35)       0.99 (0.96--1.10)
  Phosphorous          1.04 (0.82--1.32)       1.02 (0.82--1.80)
  β-carotene           0.99 (0.95--1.03)       1.10 (0.93--1.27)
  Vitamine C           0.95 (0.91--0.99)^‡^    0.89 (0.84--0.94)^†^
  Folic acid           0.93 (0.89--0.97)^\*^   0.87 (0.81--0.93)^\*^
  Cholesterol          1.01 (0.94--1.09)       0.95 (0.88--1.35)
  TFA                  1.08 (1.00--1.17)       1.05 (0.99--1.12)
  SFA                  1.22 (1.16--1.28)^†^    1.29 (1.20--1.39)^†^
  MUFA                 1.05 (0.99--1.12)       0.96 (0.91--1.00)

Model 1: crude model; Model 2: adjusted for variable.

OR, odds ratio; CI, confidence interval; BMI, body mass index; TFA, total fatty acid; SFA, saturated fatty acid; MUFA, Monounsaturated fatty acid.

^\*^p \< 0.01, ^†^p \< 0.001, ^‡^p \< 0.05.

DISCUSSION
==========

Colorectal cancer is associated with male, smoking, and alcohol consumption, and the risk of colon adenomas is higher in individuals with high BMI \[[@B4]\]. In a study of the relationship between lipoproteins, blood sugar and colorectal cancer, it was shown that an increase in triglycerides increased bile acids, and bile acid in the stool affected the intestinal mucosa \[[@B17][@B18]\]. In Korea, total cholesterol and triglycerides are correlated with colonic adenoma. Elevated blood sugar has been found to have a stronger association with colorectal cancer than with colorectal adenoma. There is also evidence that insulin resistance plays an important role in the differentiation of colon polyps into cancer and that the homeostasis model assessment-insulin resistance (HOMA-IR) value is significantly increased in colorectal cancer patients \[[@B14]\].

Because factors known to be involved in the etiology of colorectal cancer are the main items used in the diagnosis of metabolic syndrome, we predicted that there would be differences in lifestyle and dietary habits according to the presence of metabolic syndrome in colorectal cancer patients. BMI was significantly higher in colon cancer patients with metabolic syndrome, and smokers and drinkers were more likely to be in the metabolic syndrome group than in the normal group \[[@B4]\]. Metabolic syndrome has been associated with alcohol consumption and smoking, and it has been suggested that increased triglycerides and cholesterol resulting from alcohol consumption lead to obesity, an increased risk of cardiovascular disease, and increased mortality \[[@B19]\].

In middle-aged men, weight and waist-to-hip ratios are reported to be positively correlated with colorectal cancer, but the waist circumference findings are still controversial and further studies are needed \[[@B20]\]. In the present study, abdominal obesity, systolic blood pressure, and triglycerides were significantly higher in the metabolic syndrome group and lower in the HDL-cholesterol level, but the triglyceride level was within the normal range.

In a study of patients with rectal cancer, dietary patterns were associated with the development of rectal cancer, and high frequency of the pork, processed meat, and potatoes dietary pattern had an increased risk of developing colon and rectal cancer. It has been reported that consumption of fruits, vegetables, and dairy products reduces the risk of developing rectal cancer \[[@B21]\]. Metabolic syndrome and dietary factors have been reported in a variety of ways. High caloric intake and high fat intake increase the risk of metabolic syndrome by increasing oxidative stress \[[@B22]\]. It has been recommended that saturated fat be replaced with monounsaturated or polyunsaturated fatty acids, as well as reducing the total amount of fat \[[@B23]\]. In Korea, the westernization of dietary habits has increased overall food consumption and fast food intake which consequently lead to an increased intake of fat and salt, and accelerate the incidence of cardiovascular disease. There are studies that have higher carbohydrate intake in metabolic syndrome group \[[@B24]\] but there was no difference between the 2 groups in this study. However, in the metabolic syndrome group, the intake of cholesterol was high and the intake of fiber and folic acid was lower \[[@B23]\]. Therefore, to prevent metabolic syndrome, the younger age group needs to reduce fat intake and carbohydrate intake as their age increases.

In this study, the metabolic syndrome group consumed significantly higher energy, protein, and fat than the normal group and consumed fewer factors that lower blood cholesterol such as fiber, β-carotene, vitamin C, and folate, or consumed fewer antioxidant nutrients. Fatty acid intake rate was not significantly different but both groups showed unbalanced state. Since patients with colon cancer need to change their dietary habit to healthier pattern for recovery and cure after surgery, the diet should be managed to improve the health condition of metabolic syndrome if the patient has metabolic syndrome.

This study is a cross-sectional study and it is difficult to observe temporal causality in the occurrence of colorectal cancer and metabolic syndrome. In addition, we could not analyze the clinical condition of accompanying diseases more closely. The results of this study can not be generalized to patients with colorectal cancer. The absence of a control group in this study is considered to be a lack of research design. However, the results of this study suggest that the proportion of metabolic syndrome accompanying the metabolic syndrome is 34.3%, and the intake of alcohol, saturated fatty acids, fiber, vitamin C, and folic acid correlate the risk of metabolic syndrome occurrence, respectively.

In conclusion, we confirmed that weight management, decreases in fat and saturated fatty acid intake, and increases of fiber and vitamin intake should be implemented to prevent metabolic syndrome in colorectal cancer patients. In the management of patients with colorectal cancer, confirmation of the presence of metabolic syndrome and implementation of a balanced and proper diet are considered very important. Based on the present study, the effects of metabolic syndrome on disease treatment and health status along with the interaction of nutrient intake or dietary habit with risk factors need to be investigated in future prospective studies.
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